Company Quick10K Filing
UQM Technologies
10-Q 2019-03-31 Filed 2019-05-14
10-K 2018-12-31 Filed 2019-03-27
10-Q 2018-09-30 Filed 2018-10-31
10-Q 2018-06-30 Filed 2018-08-01
10-Q 2018-03-31 Filed 2018-05-10
10-K 2017-12-31 Filed 2018-03-20
10-Q 2017-09-30 Filed 2017-11-02
10-Q 2017-06-30 Filed 2017-08-07
10-Q 2017-03-31 Filed 2017-05-11
10-Q 2016-09-30 Filed 2016-11-10
10-Q 2016-06-30 Filed 2016-08-04
10-K 2016-03-31 Filed 2016-06-07
10-Q 2015-12-31 Filed 2016-02-04
10-Q 2015-09-30 Filed 2015-11-10
10-Q 2015-06-30 Filed 2015-07-30
10-K 2015-03-31 Filed 2015-05-28
10-Q 2014-12-31 Filed 2015-02-05
10-Q 2014-09-30 Filed 2014-11-05
10-Q 2014-06-30 Filed 2014-07-31
10-K 2014-03-31 Filed 2014-05-30
10-Q 2013-12-31 Filed 2014-01-30
10-Q 2013-09-30 Filed 2013-11-05
10-Q 2013-06-30 Filed 2013-08-01
10-K 2013-03-31 Filed 2013-05-23
10-Q 2012-12-31 Filed 2013-01-31
10-Q 2012-09-30 Filed 2012-10-25
10-Q 2012-06-30 Filed 2012-07-31
10-K 2012-03-31 Filed 2012-05-24
10-Q 2011-12-31 Filed 2012-01-31
10-Q 2011-09-30 Filed 2011-10-27
10-Q 2011-06-30 Filed 2011-08-01
10-K 2011-03-31 Filed 2011-06-02
10-Q 2010-12-31 Filed 2011-02-01
10-Q 2010-09-30 Filed 2010-10-28
10-Q 2010-06-30 Filed 2010-07-29
10-K 2010-03-31 Filed 2010-05-24
10-Q 2009-12-31 Filed 2010-02-02
8-K 2019-07-31
8-K 2019-07-25
8-K 2019-05-14
8-K 2019-04-23
8-K 2019-04-16
8-K 2019-03-27
8-K 2019-01-21
8-K 2018-10-31
8-K 2018-10-17
8-K 2018-08-01
8-K 2018-05-10
8-K 2018-05-09
8-K 2018-03-20
8-K 2018-03-05
8-K 2017-07-12

UQM Technologies Financials

UQM Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
Supernova Partners Acquisition Co III, Ltd. (STRE-WT)
1347 Capital Corp (TFSC)
Ameri Metro, Inc. (formerly Yellowwood) (ARMT)
Gores Technology Partners, Inc. (GTPAW)
Bioquest Corp (BQST)
BriaCell Therapeutics Corp. (BCTXW)
Ameren Illinois Co (AILNP)
DD3 Acquisition Corp. II (DDMXW)
8i Acquisition 2 Corp. (LAX)
Acumen Pharmaceuticals, Inc. (ABOS)
Aerovate Therapeutics, Inc. (AVTE)
Frontier Investment Corp (FICV)
Gobi Acquisition Corp. (GOBI)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
HEALTH REVENUE ASSURANCE HOLDINGS, INC. (HRAA)
Ocean Biomedical, Inc. (OCEA)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Cash10,93212,11011,54511,6388,7496,7805,9054,5285,3355,0716,26410,2479,4598,0477,2176,5865,6274,0188,6897,0305,4983,8621,0882,6608,5786,8095,9103,0092,8462,2153,133
Accounts Receivable2,9682,6343,9534,9295,5974,7581,4302,2122,7263,0836839608901,0158965224156796634816794844777926348241,3471,1971,2871,6811,541
Inventory3,0004,2577,99210,56412,21813,42811,41010,99810,75910,52810,25510,0549,9409,7509,6529,3549,3759,0109,0022,2719,0539,1502,0992,3572,6892,3412,8813,9104,5754,7844,816
PP&E13,16113,40113,67514,03614,20314,24814,30013,97114,10814,24814,40813,90613,92813,95314,00913,23713,28413,29213,29413,28913,30513,30713,26312,50312,51212,54912,58112,74012,82612,89213,132
Assets39,66438,85539,72239,65638,69636,97330,10628,60927,97527,78626,41229,83528,66126,85025,47824,80222,78120,79125,21223,35121,82819,94110,43311,86617,15415,13415,36113,44314,18914,01414,974
Accounts Payable8091,1521,9042,3571,4531,5498516178957055523863633511693994975953953658197828329521,3899491,1381,7432,6452,9962,679
Long-Term Debt5913,1653,1653,1653,1654,6654,665
Liabilities2,4002,6304,2255,4085,5195,7833,2083,8443,9603,8902,3802,0602,0032,1251,9712,4732,5152,6762,5671,6392,0082,2902,9735,6716,2375,3637,4317,6659,39710,00010,813
Stockholders' Equity37,26436,22535,49734,24833,17731,18926,89724,76524,01523,89624,03227,77526,65824,72623,50722,32920,26618,11522,64521,71219,82017,6517,4606,19510,9179,7717,9305,7784,7924,0144,161
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Revenue1,3152,3342,7193,7752,3961,1961,9281,6581,9492,0622,0401,0151,0201,1178361,0447411,7351,3271,5041,4351,0211,0151,7892,7532,2221,6122,7024,3855,4763,684
Cost of Revenue1,1996659091,1131,4064,175
Gross Profit4603501353918161,301
R&D41626132723415591446184133409141,088912775684719882633555403451679827397502
SG&A1,1902,0991,1501,2411,8233,1461,4341,2921,2441,6151,2201,0641,1291,7721,1341,3041,2451,8551,0731,2331,6851,7381,3031,4711,9831,6101,5202,3191,8402,692
Tax
Net Income-1,044-1,586-846-1,452-1,287-2,564-4,555-2,282-9163,226-66-1,379-1,310-1,991-1,371-1,316-2,224-2,409-1,374-931-1,954-2,368-1,606-586-543-1,281-1,933-2,470-1,142-959-2,551
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Cash Operating-2,478-2,429-3,679-2,827-3,176-1,726-1,104-1,254-541-2381,357-1,200-886-1,121-765-931-1,499-1,154-1,522-1,628-997-1,516-585-1,772-871-2,719-61-1,385
Cash Investing-2,4903,6193,1142,882272-219185-1241,344-43-19424171-118-65-49-18-23-20-11-16-291,378-54-46-197-108-255
Cash Financing22-1103816-24430418294,94327-172022-915,8479323,1165,12458181572,558